Other
Cameroon Baptist Convention Health
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
Failure Rate
20.0%
1 terminated/withdrawn out of 5 trials
Success Rate
75.0%
-11.5% vs industry average
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed trials have results
Key Signals
1 with results
Enrollment Performance
Analytics
Phase 3
2(66.7%)
N/A
1(33.3%)
3Total
Phase 3(2)
N/A(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT06377098Phase 3Withdrawn
Intrapartum Sildenafil in Laboring Mothers
Role: collaborator
NCT02766933Completed
Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study
Role: collaborator
NCT00297882Phase 3Completed
Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon
Role: collaborator
NCT02573714Not ApplicableUnknown
Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises
Role: lead
NCT02571933Completed
Face Validity and Cross-Cultural Acceptability of the FPS-R in Cameroon
Role: lead
All 5 trials loaded